Carine Vincent

Statistics

Publications

Citations

H-Index

Active since

2009

Affiliations

Carine Vincent is an author at Sanofi (France) specializing in pharmacology, pharmacokinetics of anticancer drugs, and pharmacokinetics of anticancer agents.

Publications per year

2009–2021

Publications

A Novel Selective PKR Inhibitor Restores Cognitive Deficits and Neurodegeneration in Alzheimer Disease Experimental Models

Matilde Lopez-Grancha, Patrick Bernardelli, Nicolas Moindrot et al. · Journal of Pharmacology and Experimental Therapeutics · 2021 · 31 citations · Full text

Life Sciences, Biology, Conservation Biology +14

A phase I open-label study investigating the disposition of [14C]-cabazitaxel in patients with advanced solid tumors

Laurence Ridoux, Dorothée Sémiond, Carine Vincent et al. · Anti-Cancer Drugs · 2014 · 17 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

A three-part, phase I, dose-escalation study of GSK1120212, a potent MEK inhibitor, administered orally to subjects with solid tumors or lymphoma

Dawn Thompson, K. T. Flaherty, W. Messersmith et al. · Journal of Clinical Oncology · 2009 · 13 citations

Medicine, Oncology, Pharmacology +14

1–3 of 3